Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,230 public trials 3,233 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Active, Not Recruiting

A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)

NCT05094336

Conditions
Advanced MTAP-null Solid Tumors, Biliary Tract Diseases, Biliary Tract Neoplasms, +29 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • California Research Institute Glendale, California, United States
  • Fomat Medical Research Oxnard, California, United States
  • University of California at SF San Francisco, California, United States
View all 75 locations
View Trial Details
Active, Not Recruiting

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

NCT04514484

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Differentiated Thyroid Gland Carcinoma, +141 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
  • University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

NCT02568267

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +91 more
Locations
  • Dignity Health St Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • City of Hope Cancer Center Duarte, California, United States
  • City of Hope Duarte - Comprehensive Cancer Center, Investigational Drug Services Duarte, California, United States
View all 130 locations
View Trial Details
Active, Not Recruiting

Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)

NCT04704934

Conditions
Adenocarcinoma, Carcinoma, Digestive System Diseases, +11 more
Locations
  • Instituto Medico Especializado Alexander Fleming Colegiales, Buenos Aires F.D., Argentina
  • IONC Instituto Oncologico de Cordoba - Fundacion Richardet Longo Nueva Cordoba, Córdoba Province, Argentina
  • Exelsus San Miguel de Tucumán, Tucumán Province, Argentina
  • Fundacion Cenit Buenos Aires, Argentina
View all 156 locations
View Trial Details
Active, Not Recruiting

S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP

NCT06188702

Conditions
Biliary Tract Diseases, Biliary Tract Neoplasms, Bronchial Neoplasms, +12 more
Locations
  • Lake Mary Cancer Center - Florida Cancer Specialists & Research Institute Lake Mary, Florida, United States
  • Community Health Network Indianapolis, Indiana, United States
  • Taylor Cancer Research Center Maumee, Ohio, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
View all 22 locations
View Trial Details
Active, Not Recruiting

Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer (TOPAZ-1)

NCT03875235

Conditions
Biliary Tract Diseases, Biliary Tract Neoplasms, Digestive System Diseases, +3 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Orange, California, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Fort Myers, Florida, United States
View all 126 locations
View Trial Details

Related conditions